bf/NASDAQ:FBIO_icon.jpeg

NASDAQ:FBIO

Fortress Biotech, Inc.

  • Stock

USD

Last Close

1.39

25/09 14:38

Market Cap

35.72M

Beta: 1.99

Volume Today

70.01K

Avg: 589.37K

PE Ratio

−0.12

PFCF: −0.22

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
101.50K
-
187K
84.24%
424.50K
127.01%
767.50K
80.80%
1.13M
47.30%
5.63M
398.28%
12.01M
113.22%
12.18M
1.43%
average payables
748.50K
-
417K
44.29%
1.12M
167.87%
13.08M
1,071.13%
30.32M
131.79%
35.28M
16.36%
34.83M
1.27%
38.06M
9.27%
65.67M
72.52%
94.05M
43.23%
66.13M
29.69%
average receivables
4.34M
-
13.04M
200.10%
12.49M
4.20%
11.00M
11.94%
17.25M
56.83%
21.94M
27.21%
26.07M
18.81%
21.87M
16.11%
book value per share
2.67
-
1.94
27.31%
1.21
37.90%
0.96
20.11%
1.26
31.01%
0.04
96.62%
0.48
1,024.44%
1.39
190.83%
1.33
4.54%
0.47
64.71%
2.78
492.09%
capex per share
-0.01
-
-0.25
-
-0.26
3.44%
-0.13
50.28%
-0.22
64.70%
-0.17
20.23%
-0.10
42.06%
-0.20
101.09%
-0.03
82.82%
-1.00
2,804.52%
capex to depreciation
-11.06
-
-460.81
-
-9.32
97.98%
-1.63
82.56%
-4.54
179.56%
-2.02
55.57%
-1.35
33.36%
-2.41
78.91%
-0.33
86.43%
-1.00
207.03%
capex to operating cash flow
0.01
-
0.59
-
0.23
61.00%
0.06
72.20%
0.09
48.50%
0.10
4.53%
0.09
13.47%
0.14
63.84%
0.02
87.86%
0.06
270.87%
capex to revenue
-13.88
-
-0.64
95.41%
-0.03
95.45%
-0.35
1,099.02%
-0.26
26.30%
-0.16
38.75%
-0.24
51.24%
-0.04
83.03%
-0.10
137.57%
cash per share
3.27
-
1.92
41.28%
2.08
8.43%
2.29
10.17%
3.67
60.03%
1.91
47.91%
2.50
30.81%
3.24
29.56%
3.74
15.48%
2.01
46.40%
9.98
397.43%
days of inventory on hand
6.53
-
0.39
94.07%
40.40
10,335.13%
29.70
26.49%
35.11
18.23%
112.19
219.51%
167.93
49.68%
128.94
23.22%
days payables outstanding
781.36
-
82.30
89.47%
2.04K
2,377.43%
1.23K
39.74%
1.02K
17.20%
1.03K
1.39%
1.16K
12.06%
439.79
61.95%
days sales outstanding
192.44
-
33.83
82.42%
103.10
204.74%
143.53
39.22%
160.84
12.06%
126.23
21.52%
136.60
8.21%
66.46
51.34%
debt to assets
0.14
-
0.16
17.19%
0.20
23.91%
0.17
15.95%
0.27
63.63%
0.56
108.52%
0.51
9.82%
0.27
46.73%
0.19
30.19%
0.43
128.83%
0.42
3.01%
debt to equity
0.17
-
0.20
19.96%
0.41
104.11%
0.73
78.67%
1.27
72.60%
42.93
3,293.32%
4.39
89.77%
0.89
79.79%
0.69
22.28%
3.05
342.41%
3.12
2.18%
dividend yield
0.02
-
0.00
-
0.06
3,386.24%
0.02
70.98%
0.03
62.54%
0.04
45.32%
0.15
250.87%
0.36
138.12%
earnings yield
-0.46
-
-0.23
50.46%
-0.37
60.06%
-0.51
38.69%
-0.40
21.21%
-2.25
459.55%
-0.37
83.63%
-0.45
22.45%
-0.81
78.86%
-3.67
355.36%
-2.48
32.41%
enterprise value
-5.87M
-
52.88M
1,000.42%
56.53M
6.91%
47.82M
15.41%
118.81M
148.46%
51.37M
56.76%
118.89M
131.43%
83.98M
29.36%
-26.52M
131.57%
7.29M
127.50%
32.08M
339.99%
enterprise value over ebitda
0.17
-
-2.65
1,687.24%
-1.12
57.50%
-0.74
33.83%
-1.21
62.10%
-0.44
63.51%
-1.15
160.83%
-0.90
21.35%
0.15
116.47%
-0.04
124.41%
-0.24
573.78%
ev to operating cash flow
0.20
-
-3.24
1,734.25%
-2.77
14.31%
-1.04
62.37%
-1.39
33.24%
-0.52
62.63%
-1.25
140.91%
-1.00
19.84%
0.23
122.67%
-0.04
117.86%
-0.25
515.59%
ev to sales
65.51
-
2.90
95.57%
0.63
78.17%
1.91
201.72%
3.25
69.85%
1.84
43.26%
-0.39
120.93%
0.10
124.97%
0.38
294.33%
free cash flow per share
-0.98
-
-0.45
54.13%
-0.69
52.63%
-1.41
105.33%
-2.18
54.79%
-2.49
14.13%
-1.91
23.39%
-1.26
33.85%
-1.63
28.92%
-2.05
26.22%
-16.81
718.69%
free cash flow yield
-0.37
-
-0.18
50.56%
-0.25
33.48%
-0.52
112.17%
-0.55
4.75%
-2.89
429.50%
-0.74
74.36%
-0.40
46.37%
-0.65
63.47%
-3.13
381.75%
-5.58
78.15%
graham net net
2.64
-
1.40
46.79%
1.35
3.46%
0.26
80.53%
0.98
269.84%
-0.74
175.75%
-0.11
85.65%
1.63
1,636.40%
1.93
18.64%
-0.42
121.93%
-8.43
1,888.61%
graham number
8.57
-
4.95
42.20%
5.28
6.61%
5.47
3.55%
6.75
23.51%
1.36
79.82%
3.20
134.51%
6.70
109.58%
7.77
16.04%
5.04
35.11%
21.62
328.84%
income quality
0.80
-
0.80
0.43%
0.38
52.80%
0.64
69.92%
0.86
33.16%
0.76
11.68%
0.93
23.60%
0.81
13.01%
0.71
12.99%
0.84
18.61%
2.11
152.14%
intangibles to total assets
0
-
0
0.01
Infinity%
0.21
1,903.74%
0.14
34.79%
0.01
92.70%
0.03
224.18%
0.04
36.55%
0.03
28.84%
0.09
191.92%
0.12
31.04%
interest coverage
-18.80
-
-15.43
17.91%
-34.05
120.61%
-17.81
47.70%
-17.27
3.01%
-11.61
32.81%
-9.35
19.41%
-9.71
3.87%
-11.69
20.37%
-14.83
26.79%
9.09
161.32%
interest debt per share
0.51
-
0.43
16.27%
0.53
23.19%
0.80
51.75%
1.74
117.59%
2.07
18.99%
2.32
12.28%
1.37
40.90%
1.11
19.45%
1.59
43.55%
6.78
327.42%
inventory turnover
55.91
-
942.70
1,586.21%
9.03
99.04%
12.29
36.04%
10.39
15.42%
3.25
68.70%
2.17
33.19%
2.83
30.23%
invested capital
0.17
-
0.20
19.96%
0.41
104.11%
0.73
78.67%
1.27
72.60%
42.93
3,293.32%
4.39
89.77%
0.89
79.79%
0.69
22.28%
3.05
342.41%
3.12
2.18%
market cap
80.03M
-
88.63M
10.75%
131.54M
48.42%
107.90M
17.97%
166.22M
54.05%
37.38M
77.51%
140.61M
276.19%
228.26M
62.33%
204.25M
10.52%
58.21M
71.50%
24.41M
58.06%
net current asset value
80.73M
-
51.66M
36.01%
65.44M
26.69%
21.87M
66.58%
57.73M
163.97%
-10.04M
117.40%
2.36M
123.52%
129.74M
5,392.63%
175.84M
35.53%
-13.84M
107.87%
-48.92M
253.34%
net debt to ebitda
2.44
-
1.79
26.64%
1.49
16.59%
0.93
37.35%
0.48
48.52%
-0.12
124.91%
0.21
274.88%
1.55
639.75%
1.29
16.55%
0.25
80.41%
-0.06
123.05%
net income per share
-1.22
-
-0.56
54.04%
-1.03
83.02%
-1.38
34.22%
-1.61
16.44%
-1.94
20.60%
-0.95
51.09%
-1.43
51.04%
-2.02
41.06%
-2.41
19.30%
-7.48
210.60%
operating cash flow per share
-0.97
-
-0.45
53.84%
-0.43
3.88%
-1.15
165.23%
-2.05
78.88%
-2.27
10.91%
-1.74
23.69%
-1.16
33.04%
-1.43
22.74%
-2.02
41.51%
-15.81
683.17%
payables turnover
0.47
-
4.43
849.37%
0.18
95.96%
0.30
65.96%
0.36
20.77%
0.35
1.37%
0.32
10.76%
0.83
162.79%
receivables turnover
1.90
-
10.79
468.83%
3.54
67.18%
2.54
28.17%
2.27
10.76%
2.89
27.42%
2.67
7.59%
5.49
105.52%
research and ddevelopement to revenue
34.54
-
2.13
93.83%
0.28
86.88%
3.25
1,061.76%
2.22
31.70%
1.41
36.68%
1.87
33.24%
1.78
4.94%
1.26
29.52%
return on tangible assets
-0.37
-
-0.23
38.23%
-0.41
80.82%
-0.41
0.86%
-0.32
22.92%
-0.60
91.19%
-0.24
60.77%
-0.33
38.58%
-0.43
30.98%
-0.80
86.55%
-0.41
48.58%
revenue per share
0.02
-
0.41
2,152.92%
4.50
991.91%
0.62
86.26%
0.67
8.24%
0.63
5.41%
0.84
32.96%
0.85
1.22%
10.42
1,122.61%
roe
-0.46
-
-0.29
36.77%
-0.85
194.71%
-1.43
68.00%
-1.27
11.12%
-45.44
3,471.82%
-1.98
95.65%
-1.03
48.07%
-1.52
47.77%
-5.13
238.05%
-2.69
47.54%
roic
-0.38
-
-0.26
32.46%
-0.58
125.31%
-0.81
39.59%
-0.86
6.25%
-1.47
70.31%
-0.34
76.97%
-0.44
30.22%
-0.87
96.99%
-1.05
20.89%
-1.26
19.76%
sales general and administrative to revenue
25.01
-
2.13
91.47%
0.39
81.76%
1.99
410.07%
1.52
23.56%
shareholders equity per share
2.67
-
1.94
27.31%
1.21
37.90%
0.96
20.11%
1.26
31.01%
0.04
96.62%
0.48
1,024.44%
1.39
190.83%
1.33
4.54%
0.47
64.71%
2.78
492.09%
stock based compensation to revenue
16.56
-
0.74
95.56%
0.07
89.85%
0.56
647.98%
0.36
35.53%
0.29
18.07%
0.28
3.97%
0.30
7.14%
0.20
33.61%
tangible asset value
81.28M
-
70.52M
13.23%
83.02M
17.72%
46.91M
43.49%
86.63M
84.66%
18.33M
78.85%
65.16M
255.53%
182.37M
179.90%
213.32M
16.97%
22.83M
89.30%
-18.70M
181.92%
tangible book value per share
2.67
-
1.94
27.31%
1.76
9.30%
1.17
33.33%
2.08
77.14%
0.42
79.72%
1.19
182.43%
2.53
112.68%
2.61
3.09%
0.26
90.16%
-2.31
997.60%
working capital
88.82M
-
66.39M
25.26%
89.20M
34.37%
53.07M
40.51%
115.75M
118.12%
55.59M
51.97%
110.64M
99.01%
213.61M
93.08%
245.42M
14.89%
102.72M
58.15%
32.11M
68.74%

All numbers in USD (except ratios and percentages)